Joshi G - Search Results

1

Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation.

Joshi G, Nayyar H, Kalra S, Sharma P, Munshi A, Singh S, Kumar R. Joshi G, et al. Chem Biol Drug Des. 2017 Nov;90(5):995-1006. doi: 10.1111/cbdd.13027. Epub 2017 Jul 12. Chem Biol Drug Des. 2017. PMID: 28544624

2

Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition.

Negi A, Alex JM, Amrutkar SM, Baviskar AT, Joshi G, Singh S, Banerjee UC, Kumar R. Negi A, et al. Among authors: joshi g. Bioorg Med Chem. 2015 Sep 1;23(17):5654-61. doi: 10.1016/j.bmc.2015.07.020. Epub 2015 Jul 17. Bioorg Med Chem. 2015. PMID: 26216018

3

Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents.

Joshi G, Singh PK, Negi A, Rana A, Singh S, Kumar R. Joshi G, et al. Chem Biol Interact. 2015 Oct 5;240:120-33. doi: 10.1016/j.cbi.2015.08.009. Epub 2015 Aug 20. Chem Biol Interact. 2015. PMID: 26297992 Review.

4

Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs.

Chauhan M, Sharma G, Joshi G, Kumar R. Chauhan M, et al. Among authors: joshi g. Curr Pharm Des. 2016;22(21):3226-36. doi: 10.2174/1381612822666160224142200. Curr Pharm Des. 2016. PMID: 26907945 Review.

5

Pyrimidine-fused Derivatives: Synthetic Strategies and Medicinal Attributes.

Joshi G, Nayyar H, Alex JM, Vishwakarma GS, Mittal S, Kumar R. Joshi G, et al. Curr Top Med Chem. 2016;16(28):3175-3210. doi: 10.2174/1568026616666160506145046. Curr Top Med Chem. 2016. PMID: 27150371

6

Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases.

Kumar R, Joshi G, Kler H, Kalra S, Kaur M, Arya R. Kumar R, et al. Among authors: joshi g. Med Res Rev. 2018 Jul;38(4):1073-1125. doi: 10.1002/med.21457. Epub 2017 Jul 3. Med Res Rev. 2018. PMID: 28672082 Review.

7

Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.

Kalra S, Joshi G, Munshi A, Kumar R. Kalra S, et al. Among authors: joshi g. Eur J Med Chem. 2017 Dec 15;142:424-458. doi: 10.1016/j.ejmech.2017.08.071. Epub 2017 Sep 4. Eur J Med Chem. 2017. PMID: 28911822 Review.

8

Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II.

Kaur G, Cholia RP, Joshi G, Amrutkar SM, Kalra S, Mantha AK, Banerjee UC, Kumar R. Kaur G, et al. Among authors: joshi g. Arch Pharm (Weinheim). 2018 Jun;351(6):e1800023. doi: 10.1002/ardp.201800023. Epub 2018 May 8. Arch Pharm (Weinheim). 2018. PMID: 29737542

9

Relay tricyclic Pd(ii)/Ag(i) catalysis: design of a four-component reaction driven by nitrene-transfer on isocyanide yields inhibitors of EGFR.

Sawant DM , Sharma S , Pathare RS , Joshi G , Kalra S , Sukanya S , Maurya AK , Metre RK , Agnihotri VK , Khan S , Kumar R , Pardasani RT . Sawant DM , et al. Among authors: joshi g. Chem Commun (Camb). 2018 Oct 11;54(82):11530-11533. doi: 10.1039/c8cc05845h. Chem Commun (Camb). 2018. PMID: 30137112

10

Role of 2-Dimensional Autocorrelation Descriptors in Predicting Antimalarial Activity of Artemisinin and its Aanalogues: A QSAR Study.

Kalra S, Joshi G, Kumar R, Munshi A. Kalra S, et al. Among authors: joshi g. Curr Top Med Chem. 2018;18(31):2720-2730. doi: 10.2174/1568026619666190119143838. Curr Top Med Chem. 2018. PMID: 30659538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,035 results

Search Page

Filters